Lineage Cell Therapeutics, Inc.LCTXNYSE
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
22.50%
↑ 316% above average
Average (9y)
-10.40%
Historical baseline
Range
High:159.32%
Low:-148.57%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 22.50% |
| 2023 | 20.00% |
| 2022 | 42.31% |
| 2021 | -85.71% |
| 2020 | -72.20% |
| 2019 | 77.42% |
| 2018 | -111.76% |
| 2017 | -148.57% |
| 2016 | 159.32% |
| 2015 | -7.27% |